Skip to main content

Table 5 Comparison between eNOS genotype in ESRD among clinical data

From: Association of NOS3 (rs 2070744) and SOD2Val16Ala (rs4880) gene polymorphisms with increased risk of ESRD among Egyptian patients

  eNOS genotype One-way ANOVA
4aa 4ab 4bb
Mean SD Mean SD Mean SD F P
Hb Conc. 9.67 2.17 10.27 1.42 10.16 2.16 0.609 0.546
Duration of dialysis (months) 39.05 44.30 28.40 35.73 29.48 35.01 0.583 0.56
Ca Conc. 7.94 0.69 8.38 1.22 8.33 1.23 1.051 0.354
Phosphate 6.42 2.32 4.95 1.68 6.41 2.63 4.176 0.018
PTH 466.20 397.92 397.70 249.17 529.98 534.57 0.854 0.429
Creat Conc. 7.65 2.67 9.08 3.13 7.64 3.01 2.428 0.094
Bilirubin 0.72 0.16 0.48 0.17 0.69 0.18 15.595 <0.001
Albumin 4.01 0.33 3.79 0.44 3.79 0.46 1.962 0.146
SGPT 19.20 7.36 24.33 16.47 31.84 27.02 2.824 0.064
SGOT 21.55 5.79 32.10 17.06 32.92 26.10 2.251 0.111
FBS 109.40 55.48 110.93 54.26 140.84 76.28 2.636 0.077
  No % No % No % Chi-square test
HBsAg Negative 20 100.00 30 100.00 50 100.00 NA NA
HCV Negative 18 90.00 21 70.00 35 70.00   
Positive 2 10.00 9 30.00 15 30.00 3.326 0.190